---
title: "Hikal Ltd (HIKAL) — Share Price, Financials & Analysis"
symbol: "HIKAL"
company: "Hikal Ltd"
canonical: "https://tapetide.com/stocks/HIKAL"
isin: "INE475B01022"
nse_symbol: "HIKAL"
bse_code: "524735"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 2766.62
generated_at: "2026-09-13T19:39:01.472Z"
---

# Hikal Ltd (HIKAL)

Canonical page: https://tapetide.com/stocks/HIKAL

## Company

- **NSE Symbol:** HIKAL
- **BSE Code:** 524735
- **ISIN:** INE475B01022
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2001-02-14
- **CEO:** Mr. Jai Vishwanath Hiremath
- **Employees:** 2062
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** hikal.com

## About

Hikal is a partner to companies in the Pharmaceuticals, Crop Protection, and Specialty Chemicals industry. The company is in the business of supplying research services, active ingredients and intermediates for its customers. Hikal's manufacturing facilities have been inspected and approved by leading multinational companies in the Crop protection and Pharmaceutical sectors. The Crop protection facilities are located at Taloja and Mahad {Maharashtra). The Pharmaceutical manufacturing facilities are situated in Jigani (Bengaluru) and Panoli (Gujarat). Hikal's R & D facilities are located in Pune.[1]

## Latest Price

- **Price:** ₹224.95
- **Change:** -9.83 (-4.19%)
- **Open:** ₹231.02
- **Day High:** ₹232.39
- **Day Low:** ₹221.98
- **Previous Close:** ₹234.78
- **Volume:** 902881
- **As Of:** 2026-09-11T10:25:04+00:00

## Key Fundamentals

Observed at 2026-09-11T04:41:29.292895Z.

- **Market Cap:** ₹2766.62 Cr
- **Classification:** Microcap
- **P/E (reported):** -85.8
- **EPS (TTM):** ₹-2.74
- **EPS (reported):** ₹5.49
- **Book Value:** ₹97.22
- **Price to Book:** 2.42
- **Dividend Yield:** 0.26%
- **ROE:** -4.07%
- **ROCE:** -0.96%
- **Debt to Equity:** 0.57
- **Revenue (yearly):** ₹1724.9 Cr
- **Net Income:** ₹-48.8 Cr
- **EBITDA:** ₹232.7 Cr
- **52-Week High:** ₹282.7
- **52-Week Low:** ₹146.25
- **RSI (14):** 57.02

## Tapetide Score

- **Score:** 41 / 100
- **Score date:** 2026-09-04
- **Archetype:** Cheap but Weak
- **What it means:** A low multiple sitting on weak financials. Worth establishing what the market is discounting before treating the low valuation as an opportunity — weak fundamentals often justify it.
- **Pillar profile:** Quality: Weak · Valuation: Cheap · Momentum: Flat
- **Percentile:** 17.1 (of 4473 scored stocks)
- **Confidence:** 93%
- **Data coverage:** 86%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 21.52 | 9% |
| growth | 6.03 | 9% |
| momentum | 51.65 | 12% |
| ownership | 36.24 | 24% |
| quality | 41.73 | 22% |
| valuation | 61.47 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -0.09% over past five years.
- Company has a low return on equity of 5.16% over last 3 years.
- Dividend payout has been low at 8.37% of profits over last 3 years

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 7.7% | 61.74% | 2.82% |
| ebitda margin growth | -28.48% | -24.55% | -10.54% | -23.96% |
| net income growth | -151.39% | -153.74% | -30% | -27% |
| revenue growth | -21.6% | -7.5% | -5% | 0% |
| roce | -78.17% | -108.39% | -110.93% | 9.09% |
| roe | -151.39% | -156.61% | 2.99% | -127.08% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 434.88 | 447.5 | 514.1 | 406.8 | 452.9 | 447.7 | 552.4 | 380.4 | 318.5 | 494.3 | 519.4 | 402.8 |
| Expenses | 377.36 | 382.8 | 419.7 | 348.8 | 378 | 375.6 | 429 | 355.3 | 311.3 | 411.6 | 414 | 365.8 |
| Operating Profit | 57.52 | 64.7 | 94.4 | 58 | 74.9 | 72.1 | 123.4 | 25.1 | 7.2 | 82.7 | 105.4 | 37 |
| OPM % | 13.23 | 14.46 | 18.36 | 14.26 | 16.54 | 16.1 | 22.34 | 6.6 | 2.26 | 16.73 | 20.29 | 9.19 |
| Other Income | 0.99 | 0.1 | 0.5 | 0.5 | 0.4 | 3.6 | 0.5 | 1 | 1.9 | -35.2 | -40.5 | 10.7 |
| Interest | 13.08 | 14.2 | 15.3 | 19.8 | 18.8 | 18.7 | 17.9 | 17.1 | 14.9 | 15.5 | 14.6 | 14.9 |
| Depreciation | 28.57 | 29 | 32.3 | 31.8 | 31.7 | 33.2 | 37.7 | 39.4 | 41.2 | 41.2 | 42 | 42.7 |
| Profit before tax | 16.86 | 21.6 | 47.3 | 6.9 | 24.8 | 23.8 | 68.3 | -30.4 | -47 | -9.2 | 8.3 | -9.9 |
| Tax % | 25.44 | 25.46 | 28.33 | 26.09 | 26.21 | 27.73 | 26.5 | -26.32 | -25.74 | -35.87 | -73.49 | -25.25 |
| Net Profit | 12.57 | 16.1 | 33.9 | 5.1 | 18.3 | 17.2 | 50.2 | -22.4 | -34.9 | -5.9 | 14.4 | -7.4 |
| EPS in Rs | 1.02 | 1.31 | 2.75 | 0.41 | 1.48 | 1.39 | 4.07 | -1.82 | -2.83 | -0.48 | 1.17 | -0.6 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 1296 | 1590 | 1507 | 1720 | 1943 | 2023 | 1785 | 1860 | 1713 | 1735 |
| Expenses | 1054 | 1291 | 1234 | 1398 | 1602 | 1765 | 1518 | 1531 | 1492 | 1503 |
| Operating Profit | 242 | 298 | 273 | 323 | 341 | 258 | 267 | 328 | 220 | 232 |
| OPM % | 19 | 19 | 18 | 19 | 18 | 13 | 15 | 18 | 13 | 13 |
| Other Income | 4 | 2 | -12 | 5 | 5 | 5 | 2 | 5 | -73 | -63 |
| Interest | 49 | 58 | 52 | 36 | 31 | 48 | 56 | 75 | 62 | 60 |
| Depreciation | 86 | 93 | 82 | 85 | 96 | 109 | 118 | 134 | 164 | 167 |
| Profit before tax | 112 | 149 | 127 | 206 | 219 | 105 | 96 | 124 | -78 | -58 |
| Tax % | 31 | 31 | 33 | 36 | 27 | 26 | 27 | 27 | -38 | — |
| Net Profit | 77 | 103 | 84 | 133 | 160 | 78 | 70 | 91 | -49 | -34 |
| EPS in Rs | 6.26 | 8.36 | 6.85 | 10.8 | 13.02 | 6.36 | 5.64 | 7.36 | -3.96 | -2.74 |
| Dividend Payout % | 13 | 14 | 18 | 19 | 12 | 19 | 21 | 19 | -15 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 16 | 16 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 589 | 653 | 732 | 792 | 909 | 1043 | 1109 | 1163 | 1238 | 1174 |
| Borrowings | 598 | 635 | 661 | 646 | 610 | 675 | 748 | 818 | 765 | 684 |
| Other Liabilities | 177 | 237 | 268 | 306 | 370 | 470 | 504 | 482 | 502 | 483 |
| Total Liabilities | 1379 | 1542 | 1686 | 1768 | 1913 | 2213 | 2385 | 2487 | 2529 | 2365 |
| Fixed Assets | 668 | 634 | 713 | 735 | 713 | 879 | 948 | 1071 | 1364 | 1333 |
| CWIP | 63 | 118 | 79 | 161 | 254 | 295 | 412 | 414 | 121 | 94 |
| Investments | 4 | 3 | 1 | 1 | 1 | 11 | 5 | 5 | 10 | 10 |
| Other Assets | 645 | 788 | 893 | 871 | 946 | 1028 | 1020 | 997 | 1034 | 928 |
| Total Assets | 1379 | 1542 | 1686 | 1768 | 1913 | 2213 | 2385 | 2487 | 2529 | 2365 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 163 | 139 | 186 | 285 | 229 | 294 | 315 | 187 | 280 | 302 |
| Cash from Investing Activity | -102 | -110 | -125 | -164 | -156 | -284 | -292 | -174 | -136 | -145 |
| Cash from Financing Activity | -63 | -25 | -55 | -101 | -97 | -6 | -8 | -27 | -144 | -160 |
| Net Cash Flow | -2 | 4 | 6 | 20 | -24 | 4 | 15 | -14 | 0 | -3 |
| Free Cash Flow | 58 | 33 | 57 | 127 | 71 | 21 | 13 | -17 | 144 | 154 |
| CFO/OP | 91 | 68 | 73 | 113 | 85 | 107 | 134 | 81 | 94 | 144 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 92 | 81 | 80 | 82 | 103 | 82 | 80 | 113 | 103 | 94 |
| Inventory Days | 189 | 158 | 156 | 147 | 107 | 121 | 104 | 134 | 146 | 172 |
| Days Payable | 93 | 86 | 68 | 95 | 92 | 91 | 103 | 123 | 133 | 128 |
| Cash Conversion Cycle | 188 | 153 | 168 | 135 | 118 | 112 | 81 | 124 | 116 | 138 |
| Working Capital Days | 43 | 29 | 45 | 28 | 39 | 26 | 39 | 39 | 37 | 41 |
| ROCE % | 12 | 13 | 15 | 14 | 16 | 15 | 8 | 8 | 10 | 4 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% |
| FIIs | 4.81% | 6.13% | 6.55% | 6.67% | 6.78% | 6.06% | 5.69% | 5.36% | 4.23% | 2.3% | 1.43% | 0.99% |
| DIIs | 3.12% | 3.15% | 3.53% | 3.17% | 3.58% | 3.48% | 3.8% | 4.02% | 5.16% | 7.05% | 7.2% | 7.24% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 18.19% | 17.02% | 16.45% | 16.31% | 15.81% | 16.64% | 16.57% | 16.75% | 16.66% | 16.77% | 17.18% | 17.84% |
| Others | 5.03% | 4.85% | 4.62% | 5.01% | 4.99% | 4.97% | 5.08% | 5.02% | 5.1% | 5.02% | 5.34% | 5.09% |
| No. of Shareholders | 76126 | 74657 | 71840 | 70978 | 71912 | 71801 | 68907 | 71391 | 73404 | 74117 | 74270 | 73527 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 6 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 225.26 | Sell |
| EMA (10) | 227.83 | Sell |
| SMA (20) | 218.07 | Buy |
| EMA (20) | 223.12 | Buy |
| SMA (50) | 222.32 | Buy |
| EMA (50) | 218.66 | Buy |
| SMA (100) | 211.33 | Buy |
| EMA (100) | 214.37 | Buy |
| SMA (200) | 207.15 | Buy |
| EMA (200) | 225.49 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 51.66 | Neutral |
| MACD (12,26,9) | 4.53 | Buy |
| Stochastic (14,3,3) | 62.05 | Neutral |
| ADX (14) | 28.62 | Buy |
| Williams %R (14) | -51.69 | Neutral |
| ATR (14) | 12.57 | High Volatility |
| ROC (12) | 8.34 | Buy |
| Stoch RSI (14) | 53.76 | Neutral |
| UO (7,14,28) | 52.64 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 1 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |

Based on 1 analyst ratings, observed at 2026-09-11T04:41:28.575362+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a27a408-910c-4bb4-bb04-2d564d09d7e8.pdf) |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66efc08d-9bc1-42c5-8772-1b6936a608b8.pdf) |
| 2026-08-31 | [Notice Of The 38Th Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3eebd89-3800-4794-a79b-1650c954b49e.pdf) |
| 2026-08-31 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5880ee2-72e3-4973-80ba-00212f428bbb.pdf) |
| 2026-08-31 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e3e6cb3-7bac-434c-b83b-400ee55b6607.pdf) |
| 2026-08-31 | [Letter To Members Pursuant To Regulation 36(1)(B) Of SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4bb690c-ae0b-49c5-9156-fd6a355bf57d.pdf) |
| 2026-08-27 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=718b25ba-0fec-4d52-8125-3da3d597fce3.pdf) |
| 2026-08-27 | [Communication To Shareholders-Intimation Of Tax Deduction On Dividend.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=327d116f-dfea-4340-90a2-9e85095cbd65.pdf) |
| 2026-08-26 | [Board Meeting Outcome for Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe61ff38-22f3-453d-a134-1cc1c0267cf4.pdf) |
| 2026-08-26 | [Corporate Action-Fixes Record Date For Final Dividend](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=579b2ee0-06af-4ace-8fd5-6b81ff172cad.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dbfc407b-04d6-4850-b001-f11fc8aef297.pdf) |
| 2026-06-03 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f23c3f14-a68a-4b55-935a-914cd0c15692.pdf) |
| 2025-11-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b24ce9d-2585-4f11-b69f-1252b5161ba9.pdf) |
| 2025-08-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3e181b5-ee36-4680-a30e-61445f66acbc.pdf) |
| 2025-05-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da9e26f0-ddde-4556-bac9-6e368538466d.pdf) |
| 2025-02-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81b5832b-81b1-4cab-92a4-59facd019279.pdf) |
| 2024-11-18 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2a3ecb4-f2a0-4cca-a2df-b479994f33b6.pdf) |
| 2024-08-06 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07d83676-fa41-4860-9ef8-98c3a43d8afa.pdf) |
| 2024-05-15 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b919768-8fb2-498a-9043-207cabcc9f47.pdf) |
| 2024-02-15 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e259b633-2f11-4cdf-a2e2-4846938e1d1b.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-06 | [Results- Financial Results For June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a6eabf5-265f-48cb-8511-07eebdd5c1f6.pdf) |
| 2026-05-27 | [Results- Financial Results For March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89647785-18af-4d7b-b486-78813afcd2e1.pdf) |
| 2026-02-11 | [Results-Financial Results For December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d23306ce-6f45-480b-bc1a-2a2c2816acc2.pdf) |
| 2025-11-13 | [Submission Of Unaudited Standalone And Consolidated Financial Results For The Quarter And The Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75397238-a549-48cf-a44e-e663736a4750.pdf) |
| 2025-08-07 | [Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7eb961b3-c071-49a8-afb7-8368063d90bb.pdf) |
| 2025-05-14 | [Audited Standalone And Consolidated Financial Results For The Quarter And The Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1cb33da6-beef-438a-a731-2754b6ba7960.pdf) |
| 2025-02-04 | [Submission Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024 And Declaration Of Interim Dividend For Financial Year 2024-](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7267ef39-eac2-4b12-9cfe-efef8de96238.pdf) |
| 2024-11-12 | [Submission Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half-Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d56aa8e7-5ae5-4c80-bb37-0cf0d457a7b7.pdf) |
| 2024-08-01 | [Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8aef6e00-9d92-4029-8d6d-86dcf8908fd4.pdf) |
| 2024-05-09 | [Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=671bd4fb-718b-4b15-a95a-20a2c4e3567b.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11a75987-1e27-4a68-9971-c41ab67ec317.pdf) |
| 2026-05-27 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=adf7d155-a6ca-4374-a95b-510778249ee2.pdf) |
| 2026-02-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eee9564c-bde9-4418-b7ea-9b7baee0cf40.pdf) |
| 2025-11-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66ab4388-389a-4085-8f56-600cc6246fe0.pdf) |
| 2025-09-23 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44d8d646-fee6-4c76-a4b9-1162ad0cd2d6.pdf) |
| 2025-08-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ceadab9-5729-4e46-bf9f-b1da87ff03de.pdf) |
| 2025-05-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ccb6aa0-e133-4e1a-9e16-11362459af41.pdf) |
| 2025-02-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75689304-0903-4d5f-8056-dce8b628fca7.pdf) |
| 2024-11-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a21642de-b5bc-4d52-adb7-70585cb10adb.pdf) |
| 2024-08-01 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f30eb27d-2cf0-45b7-9683-55ca30207a07.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b3fa375-cf16-4a58-97aa-0d466d52636a.pdf) |
| 2026-05-27 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c78d18a1-0855-4255-ad3b-4f203800de95.pdf) |
| 2026-02-11 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de6d9d81-bf7c-4f1e-8fd5-b2cb07751071.pdf) |
| 2025-11-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0aa0ff74-b014-43d7-98c6-578aacc22b22.pdf) |
| 2024-11-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c19a8c13-19d2-4fb3-b87a-21c6a145924d.pdf) |
| 2024-05-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=126cd56e-010d-492b-8a46-a46492623c39.pdf) |
| 2024-02-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89371142-e820-4d2e-9e58-417681c0dff7.pdf) |
| 2023-11-02 | [Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Earnings Call Audio Recording Q2 FY24](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e998e7dd-ee5b-44ac-a351-442a084bb5aa.pdf) |
| 2023-08-08 | [Intimation Under Regulation 30 Of SEBI (LODR) - Earnings Call Audio Recording Q1 FY24](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61dfffa1-bb46-4d96-b1d5-0484fd314053.pdf) |
| 2023-05-29 | [Intimation Under Regulation 30 Of SEBI (LODR) - Earnings Call Audio Recording Q4 FY23](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6110704c-a413-4d5f-86fc-6359250710c8.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2025 | [Concall - Sep 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/44d8d646-fee6-4c76-a4b9-1162ad0cd2d6.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0b24ce9d-2585-4f11-b69f-1252b5161ba9.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=968fbfdd-b8f4-470d-acdf-c217ad4e5807.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/968fbfdd-b8f4-470d-acdf-c217ad4e5807.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b2a3ecb4-f2a0-4cca-a2df-b479994f33b6.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4274679f-e09e-4380-b3e9-73d223466204.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dce4d1d0-b93f-430d-b14d-eda5aff26e36.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/adf7d155-a6ca-4374-a95b-510778249ee2.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/adf7d155-a6ca-4374-a95b-510778249ee2.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/da9e26f0-ddde-4556-bac9-6e368538466d.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a5d58290-0c1a-4312-8d0f-5fffbbae0c8b.pdf) |
| 18 Feb - Castilia Life Sciences converted to LLP; MCA certificate dated 17 Feb 2026; shareholding vested in Castilia LLP. | [Disclosure under Regulation 30A of LODR 18 Feb - Castilia Life Sciences converted to LLP; MCA certificate dated 17 Feb 2026; shareholding vested in Castilia LLP.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/af0350d3-a12e-4be8-b82a-14370abf7528.pdf) |
| 18 Feb - Castilia Life Sciences converted to LLP; 3,02,31,914 HIKAL shares (24.52%) vested; MCA certificate dated 17-Feb-2026. | [Intimation Under Regulation 7 (2) Of SEBI Prohibition Of Insider Trading Regulations, 2015 18 Feb - Castilia Life Sciences converted to LLP; 3,02,31,914 HIKAL shares (24.52%) vested; MCA certificate dated 17-Feb-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4118847e-4f84-408a-8803-7cdde34930fd.pdf) |
| 14 Apr - President-Crop Protection Mr. Vimaldeep Kulshrestha superannuates on April 14, 2026. | [Announcement under Regulation 30 (LODR)-Retirement 14 Apr - President-Crop Protection Mr. Vimaldeep Kulshrestha superannuates on April 14, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6d01824d-47b5-4e8c-b4af-952a36aa9418.pdf) |
| 10 Apr - Newspaper Publication on Special Window and Second 100-Day Campaign- Saksham Niveshak. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 10 Apr - Newspaper Publication on Special Window and Second 100-Day Campaign- Saksham Niveshak.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8cefaea3-5d90-41bb-8217-d3c973e3fdf1.pdf) |
| — | [Closure of Trading Window 25 Mar](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9820a6da-f56e-4369-a3a6-60df7bef13e3.pdf) |
| — | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 18 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0FE4A57F_61DF_4035_BE0F_840EA184BF8C_154023.pdf) |
| — | [Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 18 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9B6C7D8B_F98C_4DAB_80B5_DF451C4BE98C_154239.pdf) |
| — | [Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011 18 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/42B79A50_3CB7_4CC1_AF20_D012EFE3F228_154408.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e62f7214-3727-45c6-8b11-c2f8629ba51c.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/556b5ff1-1616-4817-a9f0-8866b86c4bd7.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5ebcb680-5476-4e58-9dcd-8494d8dda10f.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524735/74797524735.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524735/69374524735.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/524735/64888524735.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:39:01.472Z.